This article explores the growing evidence that haematopoietic cell transplantation (HCT) is a highly effective, potentially curative treatment for Chronic Granulomatous Disorder (CGD).
It highlights how earlier transplantation—before severe infections or organ damage occur—leads to better outcomes, improved quality of life, and reduced long-term complications, making a strong case for considering HCT as soon as possible after diagnosis.
It highlights how earlier transplantation—before severe infections or organ damage occur—leads to better outcomes, improved quality of life, and reduced long-term complications, making a strong case for considering HCT as soon as possible after diagnosis.